Autocrine IL-6 signaling in PCa cells induces the constitutive activation of STAT3, enhancing recruitment of the AR to the PSA promoter and rendering these cells resistant to the new generation anti-androgen Enzalutamide, which can be reversed by treatment with a STAT3 inhibitor [43]. Here, IL6 is linked to posterior cortical atrophy.